1. MUM-1 immunohistochemistry has high accuracy and reliability in the diagnosis of chronic endometritis: a multi-centre comparative study with CD-138 immunostaining
- Author
-
Leonardo Resta, Ettore Cicinelli, Amerigo Vitagliano, Dana Ben-Tzur, V Cataldo, Marco Noventa, Alessandra Andrisani, Marco Balzani, Giovanni Buzzaccarini, Sergio Haimovich, Guido Ambrosini, Nico Picardi, Dominique de Ziegler, Carlo Saccardi, Loris Marin, Nili Raz, Rossana Cicinelli, and Pantaleo Greco
- Subjects
Adult ,Infertility ,medicine.medical_specialty ,Diagnostic accuracy ,NO ,CD138 ,Recurrent miscarriage ,Genetics ,medicine ,Endometrial Polyp ,Humans ,Genetics (clinical) ,Retrospective Studies ,Gynecology ,Plasma cells ,medicine.diagnostic_test ,business.industry ,Chronic endometritis ,MUM-1 ,Reproducibility of Results ,Obstetrics and Gynecology ,General Medicine ,Gold standard (test) ,medicine.disease ,CD138, Plasma cells, Chronic endometritis, Diagnostic accuracy, MUM-1 ,Immunohistochemistry ,Reproductive Physiology and Disease ,Reproductive Medicine ,Spain ,Hysteroscopy ,Interferon Regulatory Factors ,Female ,Syndecan-1 ,Endometritis ,business ,Chronic Endometritis ,Biomarkers ,Developmental Biology ,Endometrial biopsy - Abstract
PURPOSE: The current gold standard for chronic endometritis (CE) diagnosis is immunohistochemistry (IHC) for CD-138. However, IHC for CD-138 is not exempt from diagnostic limitations. The aim of our study was to evaluate the reliability and accuracy of MUM-1 IHC, as compared with CD-138. METHODS: This is a multi-centre, retrospective, observational study, which included three tertiary hysteroscopic centres in university teaching hospitals. One hundred ninety-three consecutive women of reproductive age were referred to our hysteroscopy services due to infertility, recurrent miscarriage, abnormal uterine bleeding, endometrial polyps or myomas. All women underwent hysteroscopy plus endometrial biopsy. Endometrial samples were analysed through histology, CD138 and MUM-1 IHC. The primary outcome was to evaluate the diagnostic accuracy of MUM-1 IHC for CE, as compared with CD-138 IHC. RESULTS: Sensitivity and specificity of CD-138 and MUM-1 IHC were respectively 89.13%, 79.59% versus 93.48% and 85.03%. The overall diagnostic accuracy of MUM-1 and CD-138 IHC were similar (AUC = 0.893 vs AUC = 0.844). The intercorrelation coefficient for single measurements was high between the two techniques (ICC = 0.831, 0.761–0.881 95%CI). However, among CE positive women, MUM-1 allowed the identification of higher number of plasma cells/hpf than CD-138 (6.50 [SD 4.80] vs 5.05 [SD 3.37]; p = 0.017). Additionally, MUM-1 showed a higher inter-observer agreement as compared to CD-138. CONCLUSION: IHC for MUM-1 and CD-138 showed a similar accuracy for detecting endometrial stromal plasma cells. Notably, MUM-1 showed higher reliability in the paired comparison of the individual samples than CD-138. Thus, MUM-1 may represent a novel, promising add-on technique for the diagnosis of CE.
- Published
- 2022